SCCA Clinical Studies: Lung Cancer

SCCA was formed, in part, to bring promising new treatments to patients faster. For lung cancer patients this means more treatment options are available at SCCA than might be found elsewhere, including participation in one of many ongoing clinical trials conducted at SCCA and its parent organizations, Fred Hutchinson Cancer Research Center and UW Medicine.

To find a clinical trial:

• View the Lung Cancer Trial Finder (pictured right), where trials are organized by disease status (e.g., Newly Diagnosed, Advanced Metastatic, etc).
• Click here to view a listing of all open lung cancer trials.
• To see a list of all of SCCA's most recently opened clinical trials, follow our Twitter feed @SCCA_Trials. Likewise, the SCCABlog also regularly lists recently opened trials as well.

Our current high priority trials include:

• BMS-936558 Versus Docetaxel for Squamous Non-small Cell Lung Cancer (UW12017)
  An Open-Label Randomized Phase III Trial of BMS-936558 Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
• BMS-936558 versus Docetaxel for Non-squamous Non-small Cell Lung Cancer (UW12021)
  An Open-label Randomized Phase III Trial of BMS-936558 versus Docetaxel in Previously Treated or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC)